Correlation Between Reviva Pharmaceuticals and PolyPid

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and PolyPid at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and PolyPid into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and PolyPid, you can compare the effects of market volatilities on Reviva Pharmaceuticals and PolyPid and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of PolyPid. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and PolyPid.

Diversification Opportunities for Reviva Pharmaceuticals and PolyPid

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Reviva and PolyPid is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and PolyPid in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PolyPid and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with PolyPid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PolyPid has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and PolyPid go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and PolyPid

Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to generate 1.25 times more return on investment than PolyPid. However, Reviva Pharmaceuticals is 1.25 times more volatile than PolyPid. It trades about 0.0 of its potential returns per unit of risk. PolyPid is currently generating about -0.04 per unit of risk. If you would invest  386.00  in Reviva Pharmaceuticals Holdings on August 25, 2024 and sell it today you would lose (272.00) from holding Reviva Pharmaceuticals Holdings or give up 70.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Reviva Pharmaceuticals Holding  vs.  PolyPid

 Performance 
       Timeline  
Reviva Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Reviva Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
PolyPid 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PolyPid has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, PolyPid is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Reviva Pharmaceuticals and PolyPid Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reviva Pharmaceuticals and PolyPid

The main advantage of trading using opposite Reviva Pharmaceuticals and PolyPid positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, PolyPid can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PolyPid will offset losses from the drop in PolyPid's long position.
The idea behind Reviva Pharmaceuticals Holdings and PolyPid pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine